Literature DB >> 18323602

Crystallization and preliminary X-ray diffraction analysis of full-length and proteolytically activated pyruvate oxidase from Escherichia coli.

Annett Weidner1, Piotr Neumann, Georg Wille, Milton T Stubbs, Kai Tittmann.   

Abstract

The thiamine diphosphate- and flavin-dependent peripheral membrane enzyme pyruvate oxidase from Escherichia coli (EcPOX) has been crystallized in the full-length form and as a proteolytically activated C-terminal truncation variant which lacks the last 23 amino acids (Delta23 EcPOX). Crystals were grown by the hanging-drop vapour-diffusion method using either protamine sulfate (full-length EcPOX) or 2-methyl-2,4-pentanediol (Delta23 EcPOX) as precipitants. Native data sets were collected at a X-ray home source to a resolution of 2.9 A. The two forms of EcPOX crystallize in different space groups. Whereas full-length EcPOX crystallizes in the tetragonal space group P4(3)2(1)2 with two monomers per asymmetric unit, the crystals of Delta23 EcPOX belong to the orthorhombic space group P2(1)2(1)2(1) and contain 12 monomers per asymmetric unit.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18323602      PMCID: PMC2374146          DOI: 10.1107/S1744309108003473

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  18 in total

1.  Characterization of the proteolytic activation of pyruvate oxidase. Control by specific ligands and by the flavin oxidation-reduction state.

Authors:  P Russell; L P Hager; R B Gennis
Journal:  J Biol Chem       Date:  1977-11-10       Impact factor: 5.157

2.  Regulation by lipids of cofactor binding to a peripheral membrane enzyme: binding of thiamin pyrophosphate to pyruvate oxidase.

Authors:  T A O'Brien; R Blake; R B Gennis
Journal:  Biochemistry       Date:  1977-07-12       Impact factor: 3.162

3.  Crystalline pyruvate oxidase from Escherichia coli. II. Activation by phospholipids.

Authors:  C C Cunningham; L P Hager
Journal:  J Biol Chem       Date:  1971-03-25       Impact factor: 5.157

4.  Crystalline pyruvate oxidase from Escherichia coli. 3. Phospholipid as an allosteric effector for the enzyme.

Authors:  C C Cunningham; L P Hager
Journal:  J Biol Chem       Date:  1971-03-25       Impact factor: 5.157

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Crystalline flavin pyruvate oxidase from Escherichia coli. I. Isolation and properties of the flavoprotein.

Authors:  F R Williams; L P Hager
Journal:  Arch Biochem Biophys       Date:  1966-09-26       Impact factor: 4.013

7.  Reactivation of the lipid-depleted pyruvate oxidase system from Escherichia coli with cell envelope neutral lipids.

Authors:  C C Cunningham; L P Hager
Journal:  J Biol Chem       Date:  1975-09-25       Impact factor: 5.157

8.  Role of the tetrameric structure of Escherichia coli pyruvate oxidase in enzyme activation and lipid binding.

Authors:  A Y Wang; Y Y Chang; J E Cronan
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

9.  Role of the divalent metal cation in the pyruvate oxidase reaction.

Authors:  R Blake; T A O'Brien; R B Gennis; L P Hager
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

10.  Spectroscopic studies of pyruvate oxidase flavoprotein from Escherichia coli trapped in the lipid-activated form by cross-linking.

Authors:  M W Mather; R B Gennis
Journal:  J Biol Chem       Date:  1985-09-05       Impact factor: 5.157

View more
  2 in total

1.  Structural basis for membrane binding and catalytic activation of the peripheral membrane enzyme pyruvate oxidase from Escherichia coli.

Authors:  Piotr Neumann; Annett Weidner; Andreas Pech; Milton T Stubbs; Kai Tittmann
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-06       Impact factor: 11.205

2.  Dynamic control of endogenous metabolism with combinatorial logic circuits.

Authors:  Felix Moser; Amin Espah Borujeni; Amar N Ghodasara; Ewen Cameron; Yongjin Park; Christopher A Voigt
Journal:  Mol Syst Biol       Date:  2018-11-27       Impact factor: 11.429

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.